Travel Vaccines Market by Product and Application - Global Industry Analysis & Forecast to 2027
Published On : August 2019 Pages : 155 Category: Pharma & Healthcare Report Code : HC085175
Travel Vaccines Market by Product (Hepatitis A, Yellow Fever, Tetanus, Other) Application (Hospital, Clinic Center, Others) - Global Industry Analysis & Forecast to 2027
Industry Outlook and Trend Analysis
The Travel Vaccines Market has encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period. Travelers are at an elevated risk for many infections, including familiar diseases, for example, measles that are broadly dispersed however more typical in developing nations. Vaccines can uniquely decrease the hazard for a large number of these diseases and are an imperative part of pre-travel arrangement. Health related complexities are more prominent in emerging nations and rural regions in light of dissimilarities in clean conditions, accessible water and food bases.
Drivers and Restraints
The advent of additional age group coverage is one of the essential variables driving the market's development. While approving an immunization, the administrative authorities additionally indicate the age group endorsed for accepting the antibody. This age group is indicated on the label of the vaccine and depends on the adequacy and safety results acquired from clinical trials carries out using people from these age groups.
Regional Insights
North America will be the main market for worldwide travel vaccines market, trailed by Europe and Asia-Pacific.
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
- GlaxoSmithKline
- Sanofi Pasteur
- Seqirus
- Pfizer
- Merck & Co.
- Dynavax Technologies Corporation
- Janseen Global Services LLC
- Abbott Laboratories
- Hualan Biological Engineering Inc
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2017 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
· Travel Vaccines Market, By Product, Estimates and Forecast, 2017-2027 ($Million)
o Hepatitis A
o Yellow Fever
o Tetanus
o Other
· Travel Vaccines Market, By Applications, Estimates and Forecast, 2017-2027 ($Million)
o Hospital
o Clinic Center
o Others
· Travel Vaccines Market, By Key Players, Estimates and Forecast, 2017-2027 ($Million)
o GlaxoSmithKline
o Sanofi Pasteur
o Seqirus
o Pfizer
o Merck & Co.
o Dynavax Technologies Corporation
o Janseen Global Services LLC
o Abbott Laboratories
o Hualan Biological Engineering Inc
· Travel Vaccines Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America Travel Vaccines Market, By Country
o U.S. Travel Vaccines Market
o Canada Travel Vaccines Market
o Mexico Travel Vaccines Market
o Europe
§ Europe Travel Vaccines Market, By Country
o Germany Travel Vaccines Market
o UK Travel Vaccines Market
o France Travel Vaccines Market
o Russia Travel Vaccines Market
o Italy Travel Vaccines Market
o Rest of Europe Travel Vaccines Market
o Asia-Pacific
§ Asia-Pacific Travel Vaccines Market, By Country
o China Travel Vaccines Market
o Japan Travel Vaccines Market
o South Korea Travel Vaccines Market
o India Travel Vaccines Market
o Southeast Asia Travel Vaccines Market
o Rest of Asia-Pacific Travel Vaccines Market
o South America
§ South America Travel Vaccines Market
o Brazil Travel Vaccines Market
o Argentina Travel Vaccines Market
o Columbia Travel Vaccines Market
o Rest of South America Travel Vaccines Market
o Middle East and Africa
§ Middle East and Africa Travel Vaccines Market
o Saudi Arabia Travel Vaccines Market
o UAE Travel Vaccines Market
o Egypt Travel Vaccines Market
o Nigeria Travel Vaccines Market
o South Africa Travel Vaccines Market
o Rest of MEA Travel Vaccines Market
Table of Contents:
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. Travel Vaccines Market, By Product
5.1. Introduction
5.2. Global Travel Vaccines Revenue and Market Share by Product (2017-2027)
5.2.1. Global Travel Vaccines Revenue and Revenue Share by Product (2017-2027)
5.3. Hepatitis A
5.3.1. Global Hepatitis A Revenue and Growth Rate (2017-2027)
5.4. Yellow Fever
5.4.1. Global Yellow Fever Revenue and Growth Rate (2017-2027)
5.5. Tetanus
5.5.1. Global Tetanus Revenue and Growth Rate (2017-2027)
5.6. Other
5.6.1. Global Other Revenue and Growth Rate (2017-2027)
6. Travel Vaccines Market, By Application
6.1. Introduction
6.2. Global Travel Vaccines Revenue and Market Share by Application (2017-2027)
6.2.1. Global Travel Vaccines Revenue and Revenue Share by Application (2017-2027)
6.3. Hospital
6.3.1. Global Hospital Revenue and Growth Rate (2017-2027)
6.4. Clinic Center
6.4.1. Global Clinic Center Revenue and Growth Rate (2017-2027)
6.5. Others
6.5.1. Global Others Revenue and Growth Rate (2017-2027)
7. Travel Vaccines Market, By Region
7.1. Introduction
7.2. Global Travel Vaccines Revenue and Market Share by Regions
7.2.1. Global Travel Vaccines Revenue by Regions (2017-2027)
7.3. North America Travel Vaccines by Countries
7.3.1. North America Travel Vaccines Revenue and Growth Rate (2017-2027)
7.3.2. North America Travel Vaccines Revenue (Million USD) by Countries (2017-2027)
7.3.3. United States
7.3.3.1. United States Travel Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)
7.3.4. Canada
7.3.4.1. Canada Travel Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)
7.3.5. Mexico
7.3.5.1. Mexico Travel Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)
7.4. Europe Travel Vaccines by Countries
7.4.1. Europe Travel Vaccines Revenue and Growth Rate (2017-2027)
7.4.2. Europe Travel Vaccines Revenue (Million USD) by Countries (2017-2027)
7.4.3. Germany
7.4.3.1. Germany Travel Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.4. France
7.4.4.1. France Travel Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.5. UK
7.4.5.1. UK Travel Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.6. Russia
7.4.6.1. Russia Travel Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.7. Italy
7.4.7.1. Italy Travel Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.8. Rest of Europe
7.4.8.1. Rest of Europe Travel Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)
7.5. Asia-Pacific Travel Vaccines by Countries
7.5.1. Asia-Pacific Travel Vaccines Revenue and Growth Rate (2017-2027)
7.5.2. Asia-Pacific Travel Vaccines Revenue (Million USD) by Countries (2017-2027)
7.5.3. China
7.5.3.1. China Travel Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.4. Japan
7.5.4.1. Japan Travel Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.5. Korea
7.5.5.1. Korea Travel Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.6. India
7.5.6.1. India Travel Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.7. Southeast Asia
7.5.7.1. Southeast Asia Travel Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.8. Rest of Asia-Pacific
7.5.8.1. Rest of Asia-Pacific Travel Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)
7.6. South America Travel Vaccines by Countries
7.6.1. South America Travel Vaccines Revenue and Growth Rate (2017-2027)
7.6.2. South America Travel Vaccines Revenue (Million USD) by Countries (2017-2027)
7.6.3. Brazil
7.6.3.1. Brazil Travel Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.4. Argentina
7.6.4.1. Argentina Travel Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.5. Columbia
7.6.5.1. Columbia Travel Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.6. Rest of South America
7.6.6.1. Rest of South America Travel Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)
7.7. Middle East and Africa Travel Vaccines by Countries
7.7.1. Middle East and Africa Travel Vaccines Revenue and Growth Rate (2017-2027)
7.7.2. Middle East and Africa Travel Vaccines Revenue (Million USD) by Countries (2017-2027)
7.7.3. Saudi Arabia
7.7.3.1. Saudi Arabia Travel Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.4. United Arab Emirates
7.7.4.1. United Arab Emirates Travel Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.5. Egypt
7.7.5.1. Egypt Travel Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.6. Nigeria
7.7.6.1. Nigeria Travel Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.7. South Africa
7.7.7.1. South Africa Travel Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.8. Turkey
7.7.8.1. Turkey Travel Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.9. Rest of Middle East and Africa
7.7.9.1. Rest of Middle East and Africa Travel Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)
8. Company Profiles
8.1. GlaxoSmithKline
8.1.1. Business Overview
8.1.2. Service Portfolio
8.1.3. Strategic Developments
8.1.4. Financial Overview
8.2. Sanofi Pasteur
8.2.1. Business Overview
8.2.2. Service Portfolio
8.2.3. Strategic Developments
8.2.4. Financial Overview
8.3. Seqirus
8.3.1. Business Overview
8.3.2. Service Portfolio
8.3.3. Strategic Developments
8.3.4. Financial Overview
8.4. Pfizer
8.4.1. Business Overview
8.4.2. Service Portfolio
8.4.3. Strategic Developments
8.4.4. Financial Overview
8.5. Merck & Co.
8.5.1. Business Overview
8.5.2. Service Portfolio
8.5.3. Strategic Developments
8.5.4. Financial Overview
8.6. Dynavax Technologies Corporation
8.6.1. Business Overview
8.6.2. Service Portfolio
8.6.3. Strategic Developments
8.6.4. Financial Overview
8.7. Janseen Global Services LLC
8.7.1. Business Overview
8.7.2. Service Portfolio
8.7.3. Strategic Developments
8.7.4. Financial Overview
8.8. Abbott Laboratories
8.8.1. Business Overview
8.8.2. Service Portfolio
8.8.3. Strategic Developments
8.8.4. Financial Overview
8.9. Hualan Biological Engineering Inc
8.9.1. Business Overview
8.9.2. Service Portfolio
8.9.3. Strategic Developments
8.9.4. Financial Overview
9. Travel Vaccines Market Forecast (2017-2027)
9.1. Global Travel Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)
9.2. Travel Vaccines Market Forecast by Regions (2017-2027)
9.2.1. North America Travel Vaccines Market Forecast (2017-2027)
9.2.1.1. United States Travel Vaccines Market Forecast (2017-2027)
9.2.1.2. Canada Travel Vaccines Market Forecast (2017-2027)
9.2.1.3. Mexico Travel Vaccines Market Forecast (2017-2027)
9.2.2. Europe Travel Vaccines Market Forecast (2017-2027)
9.2.2.1. Germany Travel Vaccines Market Forecast (2017-2027)
9.2.2.2. France Travel Vaccines Market Forecast (2017-2027)
9.2.2.3. UK Travel Vaccines Market Forecast (2017-2027)
9.2.2.4. Russia Travel Vaccines Market Forecast (2017-2027)
9.2.2.5. Italy Travel Vaccines Market Forecast (2017-2027)
9.2.2.6. Rest of Europe Travel Vaccines Market Forecast (2017-2027)
9.2.3. Asia-Pacific Travel Vaccines Market Forecast (2017-2027)
9.2.3.1. China Travel Vaccines Market Forecast (2017-2027)
9.2.3.2. Japan Travel Vaccines Market Forecast (2017-2027)
9.2.3.3. Korea Travel Vaccines Market Forecast (2017-2027)
9.2.3.4. India Travel Vaccines Market Forecast (2017-2027)
9.2.3.5. Southeast Asia Travel Vaccines Market Forecast (2017-2027)
9.2.3.6. Rest of Asia-Pacific Travel Vaccines Market Forecast (2017-2027)
9.2.4. South America Travel Vaccines Market Forecast (2017-2027)
9.2.4.1. Brazil Travel Vaccines Market Forecast (2017-2027)
9.2.4.2. Argentina Travel Vaccines Market Forecast (2017-2027)
9.2.4.3. Columbia Travel Vaccines Market Forecast (2017-2027)
9.2.4.4. Rest of South America Travel Vaccines Market Forecast (2017-2027)
9.2.5. Middle East and Africa Travel Vaccines Market Forecast (2017-2027)
9.2.5.1. Saudi Arabia Travel Vaccines Market Forecast (2017-2027)
9.2.5.2. United Arab Emirates Travel Vaccines Market Forecast (2017-2027)
9.2.5.3. Egypt Travel Vaccines Market Forecast (2017-2027)
9.2.5.4. Nigeria Travel Vaccines Market Forecast (2017-2027)
9.2.5.5. South Africa Travel Vaccines Market Forecast (2017-2027)
9.2.5.6. Turkey Travel Vaccines Market Forecast (2017-2027)
9.2.5.7. Rest of Middle East and Africa Travel Vaccines Market Forecast (2017-2027)
9.3. Travel Vaccines Market Forecast by Product (2017-2027)
9.3.1. Travel Vaccines Forecast by Product (2017-2027)
9.3.2. Travel Vaccines Market Share Forecast by Product (2017-2027)
9.4. Travel Vaccines Market Forecast by Application (2017-2027)
9.4.1. Travel Vaccines Forecast by Application (2017-2027)
9.4.2. Travel Vaccines Market Share Forecast by Application (2017-2027)
List of Tables
List of Tables and Figures:
Figure United States Travel Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure Canada Travel Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure Mexico Travel Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure Germany Travel Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure France Travel Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure UK Travel Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure Russia Travel Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure Italy Travel Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Europe Travel Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure China Travel Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure Japan Travel Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure Korea Travel Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure India Travel Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure Southeast Asia Travel Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Asia-Pacific Travel Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure Brazil Travel Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure Argentina Travel Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure Columbia Travel Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of South America Travel Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure Saudi Arabia Travel Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure United Arab Emirates Travel Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure Egypt Travel Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure Nigeria Travel Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure South Africa Travel Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure Turkey Travel Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Middle East and Africa Travel Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Table Global Travel Vaccines Revenue and Revenue Share by Product (2017-2018)
Figure Global Hepatitis A Revenue and Growth Rate (2017-2018)
Figure Global Yellow Fever Revenue and Growth Rate (2017-2018)
Figure Global Tetanus Revenue and Growth Rate (2017-2018)
Figure Global Other Revenue and Growth Rate (2017-2018)
Table Global Travel Vaccines Revenue and Revenue Share by Application (2017-2018)
Figure Global Hospital Revenue and Growth Rate (2017-2018)
Figure Global Clinic Center Revenue and Growth Rate (2017-2018)
Figure Global Others Revenue and Growth Rate (2017-2018)
Table Global Travel Vaccines Revenue by Regions (2017-2018)
Figure North America Travel Vaccines Growth Rate (2017-2018)
Figure North America Travel Vaccines Revenue and Growth Rate (2017-2018)
Figure North America Travel Vaccines by Countries (2017-2018)
Figure North America Travel Vaccines Revenue (Million USD) by Countries (2017-2018)
Figure United States Travel Vaccines Growth Rate (2017-2018)
Figure United States Travel Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Canada Travel Vaccines Growth Rate (2017-2018)
Figure Canada Travel Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Mexico Travel Vaccines Growth Rate (2017-2018)
Figure Mexico Travel Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Europe Travel Vaccines Growth Rate (2017-2018)
Figure Europe Travel Vaccines Revenue and Growth Rate (2017-2018)
Figure Europe Travel Vaccines by Countries (2017-2018)
Figure Europe Travel Vaccines Revenue (Million USD) by Countries (2017-2018)
Figure Germany Travel Vaccines Growth Rate (2017-2018)
Figure Germany Travel Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure France Travel Vaccines Growth Rate (2017-2018)
Figure France Travel Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure UK Travel Vaccines Growth Rate (2017-2018)
Figure UK Travel Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Russia Travel Vaccines Growth Rate (2017-2018)
Figure Russia Travel Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Italy Travel Vaccines Growth Rate (2017-2018)
Figure Italy Travel Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Europe Travel Vaccines Growth Rate (2017-2018)
Figure Rest of Europe Travel Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Asia-Pacific Travel Vaccines Growth Rate (2017-2018)
Figure Asia-Pacific Travel Vaccines Revenue and Growth Rate (2017-2018)
Figure Asia-Pacific Travel Vaccines by Countries (2017-2018)
Figure Asia-Pacific Travel Vaccines Revenue (Million USD) by Countries (2017-2018)
Figure China Travel Vaccines Growth Rate (2017-2018)
Figure China Travel Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Japan Travel Vaccines Growth Rate (2017-2018)
Figure Japan Travel Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Korea Travel Vaccines Growth Rate (2017-2018)
Figure Korea Travel Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure India Travel Vaccines Growth Rate (2017-2018)
Figure India Travel Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Southeast Asia Travel Vaccines Growth Rate (2017-2018)
Figure Southeast Asia Travel Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Travel Vaccines Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Travel Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South America Travel Vaccines Growth Rate (2017-2018)
Figure South America Travel Vaccines Revenue and Growth Rate (2017-2018)
Figure South America Travel Vaccines by Countries (2017-2018)
Figure South America Travel Vaccines Revenue (Million USD) by Countries (2017-2018)
Figure Brazil Travel Vaccines Growth Rate (2017-2018)
Figure Brazil Travel Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Argentina Travel Vaccines Growth Rate (2017-2018)
Figure Argentina Travel Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Columbia Travel Vaccines Growth Rate (2017-2018)
Figure Columbia Travel Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of South America Travel Vaccines Growth Rate (2017-2018)
Figure Rest of South America Travel Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Middle East and Africa Travel Vaccines Growth Rate (2017-2018)
Figure Middle East and Africa Travel Vaccines Revenue and Growth Rate (2017-2018)
Figure Middle East and Africa Travel Vaccines by Countries (2017-2018)
Figure Middle East and Africa Travel Vaccines Revenue (Million USD) by Countries (2017-2018)
Figure Saudi Arabia Travel Vaccines Growth Rate (2017-2018)
Figure Saudi Arabia Travel Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure United Arab Emirates Travel Vaccines Growth Rate (2017-2018)
Figure United Arab Emirates Travel Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Egypt Travel Vaccines Growth Rate (2017-2018)
Figure Egypt Travel Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Nigeria Travel Vaccines Growth Rate (2017-2018)
Figure Nigeria Travel Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South Africa Travel Vaccines Growth Rate (2017-2018)
Figure South Africa Travel Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Turkey Travel Vaccines Growth Rate (2017-2018)
Figure Turkey Travel Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Travel Vaccines Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Travel Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Table GlaxoSmithKline Travel Vaccines Financial Overview
Table Sanofi Pasteur Travel Vaccines Financial Overview
Table Seqirus Travel Vaccines Financial Overview
Table Pfizer Travel Vaccines Financial Overview
Table Merck & Co. Travel Vaccines Financial Overview
Table Dynavax Technologies Corporation Travel Vaccines Financial Overview
Table Janseen Global Services LLC Travel Vaccines Financial Overview
Table Abbott Laboratories Travel Vaccines Financial Overview
Table Hualan Biological Engineering Inc Travel Vaccines Financial Overview
Figure Global Travel Vaccines Revenue (Millions USD) and Growth Rate (2018-2025)
Table Travel Vaccines Market Forecast by Regions (2018-2025)
Figure North America Travel Vaccines Market Forecast (2018-2025)
Figure United States Travel Vaccines Market Forecast (2018-2025)
Figure Canada Travel Vaccines Market Forecast (2018-2025)
Figure Mexico Travel Vaccines Market Forecast (2018-2025)
Figure Europe Travel Vaccines Market Forecast (2018-2025)
Figure Germany Travel Vaccines Market Forecast (2018-2025)
Figure France Travel Vaccines Market Forecast (2018-2025)
Figure UK Travel Vaccines Market Forecast (2018-2025)
Figure Russia Travel Vaccines Market Forecast (2018-2025)
Figure Italy Travel Vaccines Market Forecast (2018-2025)
Figure Rest of Europe Travel Vaccines Market Forecast (2018-2025)
Figure Asia-Pacific Travel Vaccines Market Forecast (2018-2025)
Figure China Travel Vaccines Market Forecast (2018-2025)
Figure Japan Travel Vaccines Market Forecast (2018-2025)
Figure Korea Travel Vaccines Market Forecast (2018-2025)
Figure India Travel Vaccines Market Forecast (2018-2025)
Figure Southeast Asia Travel Vaccines Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Travel Vaccines Market Forecast (2018-2025)
Figure South America Travel Vaccines Market Forecast (2018-2025)
Figure Brazil Travel Vaccines Market Forecast (2018-2025)
Figure Argentina Travel Vaccines Market Forecast (2018-2025)
Figure Columbia Travel Vaccines Market Forecast (2018-2025)
Figure Rest of South America Travel Vaccines Market Forecast (2018-2025)
Figure Middle East and Africa Travel Vaccines Market Forecast (2018-2025)
Figure Saudi Arabia Travel Vaccines Market Forecast (2018-2025)
Figure United Arab Emirates Travel Vaccines Market Forecast (2018-2025)
Figure Egypt Travel Vaccines Market Forecast (2018-2025)
Figure Nigeria Travel Vaccines Market Forecast (2018-2025)
Figure South Africa Travel Vaccines Market Forecast (2018-2025)
Figure Turkey Travel Vaccines Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Travel Vaccines Market Forecast (2018-2025)
Figure Global Travel Vaccines Forecast by Product (2018-2025)
Figure Global Travel Vaccines Market Share Forecast by Product (2018-2025)
Figure Global Travel Vaccines Forecast by Product (2018-2025)
Figure Global Travel Vaccines Forecast by Application (2018-2025)
Figure Global Travel Vaccines Market Share Forecast by Application (2018-2025)
Figure Global Travel Vaccines Forecast by Application (2018-2025)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|